Recombinant Vespa mandarinia Venom allergen 5

What is Vespa mandarinia Venom allergen 5 (Vesp m 5)?

Vesp m 5 is a major allergen found in the venom of Vespa mandarinia (Asian giant hornet). It belongs to the Antigen 5 family of proteins commonly found in vespid venoms. This allergen has partial (approximately 50%) sequence identity with venom allergen 5 found in yellow jackets, yellow hornets, and bald-faced hornets . Like other Antigen 5 proteins, Vesp m 5 plays a significant role in triggering IgE-mediated allergic reactions in sensitized individuals.

How does Vesp m 5 compare structurally to other vespid allergen 5 proteins?

Vesp m 5 shares structural similarities with other vespid Antigen 5 proteins, including Ves v 5 from Vespula vulgaris (common wasp). These proteins demonstrate extensive cross-reactivity due to conserved structural elements . The partial sequence identity (approximately 50%) between Vesp m 5 and other vespid allergen 5 proteins explains the cross-reactive nature of these allergens . This structural similarity creates challenges for diagnostic specificity but provides opportunities for broader immunotherapeutic approaches.

What are the primary immunological characteristics of Vesp m 5?

Vesp m 5, like other vespid Antigen 5 proteins, contains both B-cell and T-cell epitopes that contribute to its allergenicity. Research using computational tools has identified multiple epitopes: ten linear and five discontinuous B-cell epitopes, along with three T-cell epitopes demonstrating efficient binding and immunogenicity . These epitopes are crucial for understanding the allergen's interaction with the immune system and developing targeted immunotherapeutic approaches.

How can recombinant Vesp m 5 be produced for research purposes?

Recombinant production of Vesp m 5 typically involves heterologous expression systems similar to those used for other vespid allergens. Based on methodologies for related proteins, expression in yeast systems like Pichia pastoris has been successful for producing functionally comparable allergens . The recombinant protein production process generally includes:

• Gene cloning and optimization for the expression system

• Transformation into the expression host

• Induction of protein expression

• Purification using affinity chromatography

• Verification of structural and immunological properties

These recombinant proteins are essential for standardized research applications, including epitope mapping, cross-reactivity studies, and development of diagnostic tools.

What analytical methods are most effective for characterizing recombinant Vesp m 5?

Characterization of recombinant Vesp m 5 requires multiple analytical approaches:

• Mass spectrometry techniques, particularly SWATH-MS (Sequential Window Acquisition of all Theoretical Fragment Ion Mass Spectra), allow for precise identification and quantification

• Immunological assays including ELISA to evaluate IgE binding capacity

• Basophil activation tests to assess allergenic activity

• Circular dichroism spectroscopy to analyze secondary structure

• Size-exclusion chromatography to confirm protein homogeneity

These methods collectively ensure that the recombinant protein accurately represents the native allergen's structural and immunological properties.

How do B-cell and T-cell epitopes of Vesp m 5 compare with other vespid allergen 5 proteins?

Computational studies have identified distinct epitope profiles for Vesp m 5 compared to related allergens like Ves g 5 from Vespula germanica. Research has revealed that Vesp m 5 contains ten linear and five discontinuous B-cell epitopes, while Ves g 5 has nine linear and four discontinuous B-cell epitopes . Additionally, Vesp m 5 has three predicted T-cell epitopes showing efficient binding and immunogenicity, whereas Ves g 5 has four such epitopes .

These differences in epitope profiles may explain variations in allergenic potency and cross-reactivity patterns between species. The epitope mapping data provides critical information for developing targeted immunotherapeutic approaches that could specifically address Vesp m 5 sensitization.

What are the cross-reactivity patterns between Vesp m 5 and other hymenoptera venom allergens?

Cross-reactivity between Vesp m 5 and other vespid Antigen 5 proteins is extensive but not complete:

• Vesp m 5 shares approximately 50% sequence identity with Antigen 5 proteins from yellow jackets, yellow hornets, and bald-faced hornets

• This partial homology creates significant cross-reactivity that complicates diagnostic specificity

• Ves v 5 (from Vespula vulgaris) exhibits extensive cross-reactivity with Antigen 5 proteins from various vespids, including Vesp m 5

• Unlike cross-reactivity between vespid and honeybee venoms (which involves carbohydrate determinants), cross-reactivity among vespid Antigen 5 proteins is primarily based on protein structural similarities

Understanding these cross-reactivity patterns is crucial for developing accurate diagnostic tools and effective immunotherapies for patients with Vespa mandarinia venom allergy.

What computational approaches improve prediction of allergenic epitopes in Vesp m 5?

Advanced computational methods have significantly enhanced epitope prediction accuracy for Vesp m 5:

• For B-cell epitope prediction:

  • BepiPred-2.0 algorithm utilizes random forest regression for linear epitope identification

  • ABCPred employs artificial neural networks to achieve higher prediction accuracy

  • ElliPro identifies discontinuous epitopes based on protein 3D structure

• For T-cell epitope prediction:

  • Major histocompatibility complex (MHC)-II binding prediction tools evaluate peptide-MHC interactions

  • CD4+ T-cell immunogenicity prediction tools confirm the immunogenic potential of predicted epitopes

These computational approaches provide efficient preliminary screening of potential epitopes, guiding subsequent experimental validation and reducing the time and resources required for epitope mapping.

What is the differential expression of Vesp m 5 between castes, and what are its implications?

Studies on related hornet species provide insights into potential differential expression patterns of Vesp m 5. In Vespa crabro (European hornet), venom allergen 5 (Vesp v 5) is significantly downregulated in gynes (reproductive females) compared to workers . This differential expression may reflect evolutionary adaptations related to the different ecological roles of hornet castes.

The implications of these expression differences include:

• Potential variations in sting allergenic potency between different castes

• Evolutionary insights into venom composition adaptation

• Considerations for venom collection and standardization for immunotherapy

• Potential targets for understanding regulatory mechanisms of venom protein expression

This caste-specific expression pattern provides an additional layer of complexity when studying venom allergens and developing standardized diagnostic and therapeutic approaches.

How can naturally occurring hypoallergenic variants inform the design of modified Vesp m 5 for immunotherapy?

Naturally occurring hypoallergenic variants of vespid Antigen 5, such as Poly s 5 from Polybia scutellaris, provide valuable models for developing modified Vesp m 5 with reduced allergenicity. Poly s 5 induces IgG antibodies that cross-react with allergenic Antigen 5 variants while showing minimal IgE induction and poor basophil degranulation capacity .

Key lessons from hypoallergenic variants include:

• Amino acid substitutions in the N-terminal region can alter surface topography and electrostatic potential of epitopes

• Modified variants can retain T-cell epitopes necessary for immunotherapy while reducing IgE binding

• Recombinant expression systems like Pichia pastoris can successfully produce these modified proteins

• Serum from subjects immunized with hypoallergenic variants can inhibit allergenic protein-induced basophil degranulation

These insights provide a rational basis for engineering recombinant Vesp m 5 variants with improved safety profiles for venom immunotherapy while maintaining immunogenicity.

What methodological approaches are most effective for validating in silico predictions of Vesp m 5 epitopes?

Validating computationally predicted epitopes requires a multi-faceted experimental approach:

• Peptide synthesis and binding assays:

  • Synthesize predicted epitope peptides

  • Measure binding to patient-derived IgE antibodies using ELISA or surface plasmon resonance

• Functional cellular assays:

  • Basophil activation tests using patient blood samples

  • T-cell proliferation assays to validate T-cell epitopes

• Structural confirmation:

  • X-ray crystallography or cryo-electron microscopy of allergen-antibody complexes

  • Hydrogen/deuterium exchange mass spectrometry to map binding interfaces

• Mutational analysis:

  • Site-directed mutagenesis of predicted epitope residues

  • Evaluation of mutants' IgE-binding and allergenic activity

These complementary approaches provide robust validation of predicted epitopes and inform the development of hypoallergenic variants for immunotherapy.

What are the implications of Vesp m 5 research for venom immunotherapy development?

Research on Vesp m 5 has significant implications for venom immunotherapy (VIT):

• Diagnostic precision:

  • Component-resolved diagnostics using recombinant Vesp m 5 enables identification of true Vespa mandarinia sensitization

  • Distinguishes between cross-reactivity and genuine double sensitization in patients reactive to multiple venoms

• Therapeutic considerations:

  • Current evidence suggests insufficient cross-protection from conventional vespid immunotherapy against Vespa mandarinia allergy

  • Epitope mapping facilitates development of peptide-based vaccines targeting specific epitopes

• Safety improvements:

  • Understanding of B-cell and T-cell epitopes allows for rational design of hypoallergenic variants

  • These variants could reduce side effects during immunotherapy while maintaining efficacy

• Standardization opportunities:

  • Recombinant production enables consistent allergen composition for therapy

  • Quantitative analysis methods like SWATH-MS provide tools for quality control

This research represents a critical step toward developing safer, more effective immunotherapy options for patients with life-threatening allergies to Vespa mandarinia venom.

Comparative Data on Vespid Antigen 5 Allergens